EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

“Monocytes in B-Cell Malignancies: Their Role in Disease Progression and Therapy Resistance”

Katsiaryna Marhelava, Justyna Jakubowska, Agata Pastorczak, Malgorzata Firczuk

Current Oncology Reports · 2025

DOI: 10.1007/s11912-025-01732-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology Reports, 2025. Verfasst von Katsiaryna Marhelava und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawinskiego Str, Warsaw, 02-106, Poland. kmarhelava@i…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Monocytes, Lymphoma, B-Cell, Leukemia, B-Cell. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Polish National Science Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of Review Although current treatments have improved outcomes in B-cell malignancies, therapy resistance remains a major challenge and is often driven by the tumor microenvironment. The purpose of this review was to assess the roles of monocytes and monocyte-derived cells in leukemia and lymphoma and to evaluate the potential of therapies targeting these populations. Recent Findings Recent studies indicate that monocytes and monocyte-derived cells are associated with poor prognosis, therapy resistance, and treatment-related side effects in B-cell malignancies. These cells can suppress anti-tumor immunity, support malignant cell survival, and impair therapeutic efficacy. Strategies to deplete or reprogram these populations have shown promise in restoring immune function and enhancing the effectiveness of current treatments. Summary Targeting suppressive monocyte-derived populations offers a promising strategy to overcome therapy resistance and improve outcomes in B-cell malignancies. Modulating these cells may reduce relapses, enhance treatment responses, and provide a foundation for the development of next-generation immunotherapies. Nevertheless, further studies are needed to better define the immunosuppressive and therapy-relevant subpopulations in specific diseases, which will be critical to translating these strategies into effective clinical interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmMonocytesLymphoma, B-CellLeukemia, B-CellHumansTumor MicroenvironmentDisease ProgressionB-LymphocytesImmunotherapy

Stichwörter der Autor:innen

B-cell malignanciesMonocytesTherapeutic strategiesTherapy resistanceTumor microenvironment

Autor:innen und Institutionen

  • Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawinskiego Str, Warsaw, 02-106, Poland. kmarhelava@imdik.pan.pl.
  • Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.
  • Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz, Poland.
  • Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawinskiego Str, Warsaw, 02-106, Poland.
  • Department of Immunology, Medical University of Warsaw, Warsaw, Poland.

Förderung

  • Polish National Science Centre

Zitieren

APA

Marhelava, K., Jakubowska, J., Pastorczak, A., & Firczuk, M. (2025). “Monocytes in B-Cell Malignancies: Their Role in Disease Progression and Therapy Resistance”. Current Oncology Reports. https://doi.org/10.1007/s11912-025-01732-9

Vancouver

Marhelava K, Jakubowska J, Pastorczak A, Firczuk M. “Monocytes in B-Cell Malignancies: Their Role in Disease Progression and Therapy Resistance”. Current Oncology Reports. 2025. doi:10.1007/s11912-025-01732-9

BibTeX
@article{Marhelava2025,
  author = {Marhelava, Katsiaryna and Jakubowska, Justyna and Pastorczak, Agata and Firczuk, Malgorzata},
  title = {“Monocytes in B-Cell Malignancies: Their Role in Disease Progression and Therapy Resistance”},
  journal = {Current Oncology Reports},
  year = {2025},
  doi = {10.1007/s11912-025-01732-9}
}
Kostenlos starten →